Sustained minimal residual disease in myeloma

Blood. 2022 Jan 27;139(4):469-471. doi: 10.1182/blood.2021013199.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Multiple Myeloma* / therapy
  • Neoplasm, Residual